Table 2.
Specific pathogens in respiratory samples during the study period
| Type of pathogen | Days 0–7 after intubation | Days 8–14 after intubation | Days 15–21 after intubation | Positive samples |
|---|---|---|---|---|
| A. fumigatus | 2 | 5 | 5 | 12 |
| HSV | 2 | 5 | 12 | 19 |
| CMV | 2 | 2 | 4 | 8 |
| A. baumanii complex | 2 | 3 | 5 | |
| C. koseri | 1 | 1 | ||
| E. cloacae complex | 1 | 5 | 6 | |
| E. coli | 1 | 1 | ||
| K. aerogenes | 3 | 1 | 1 | 5 |
| K. pneumoniae | 2 | 4 | 6 | |
| P. aeruginosa | 1 | 6 | 7 | |
| Pseudomonas spp. | 1 | 1 | ||
| S. aureus | 1 | 1 | ||
| S. aureus (MRSA) | 1 | 1 | ||
| S. maltophilia | 1 | 2 | 3 | |
| Viridans group streptococci | 1 | 1 |
Abbreviations: CMV, cytomegalovirus; HSV, herpes simplex virus; MRSA, methicillin‐resistant Staphylococcus aureus.